Evidence map›Paper›PMID 41353281›Full record

ArticleScientific reports2025

Extraction, LC-QTOF-MS profiling of bacterial menaquinone (MK) and characterization of CuFe

Reem M Farsi, Mohamed S Abdelwahab

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Reem M FarsiFaculty of Science, Department of Biological Sciences, King Abdul-Aziz University, Jeddah, Saudi Arabia. rfarsi@kau.edu.sa.
Mohamed S AbdelwahabFaculty of Education, Physics and Chemistry Department, Matrouh University, Mersa Matrouh, Egypt. mohamed-said-science@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferrite nanoparticles (FNPs), especially copper ferrite nanoparticles (CuFe₂O₄ NPs), are a promising platform in nanomedicine for targeted cancer treatment. Consequently, unique CuFe₂O₄ NPs were functionalized with a bioactive extract derived from Salinicoccus sp. RM1, a halophilic bacterial strain obtained from the Red Sea. The bacterial extract, abundant in menaquinone (MK) homologs (MK-4 to MK-13) as verified by LC-QTOF-MS, used as an excellent functionalizing agent to produced MK-loaded nanoparticles (CuFe₂O₄ NPs-MK). Prepared NPs were analyzed using XRD, FT-IR, SEM, EDX, particle size analysis and magnetic susceptibility analysis, confirming the effective production and functionalization of the NPs. CuFe

Indexed as

Antineoplastic AgentsCopperFerric CompoundsMetal NanoparticlesNanoparticlesVitamin K 2ApoptosisChromatography, LiquidHumansMCF-7 CellsAntineoplastic AgentsCopperFerric CompoundsVitamin K 2AnticancerBAXBCL-2CuFe₂O₄ NPsGene expressionLC-QTOF-MSMCF-7Menaquinone (MK)

Identifiers

PMID41353281
PMCPMC12789059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.